LD-2 disclosure · 1st Quarter - Report
APOTEX CORP.
via APOTEX CORP.
Expenses$140Kself-filed spend
Client
- Name
- APOTEX CORP.
- Location
- Florida · United States of America
Registrant
- Firm
- APOTEX CORP.
- Description
- Generic pharmaceutical manufacturer
- Location
- WESTON, Florida, United States of America
Lobbying activities
2 issuesHealth Issues
S 1114, the Expanding Access to Low-Cost Generics Act, provisions relating to the amendment of the Hatch-Waxman Act's 180-day exclusivity framework
LobbyistsSTEVEN GIULI
TargetedSENATE · HOUSE OF REPRESENTATIVES
Manufacturing
Federal policy relating to the strengthening domestic pharmaceutical manufacturing capabilities
LobbyistsSTEVEN GIULI
TargetedSENATE · HOUSE OF REPRESENTATIVES